Request a FREE Sample of our FcRn Binding Kit!Request a FREE Sample of our FcRn Binding Kit!
Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Request a FREE sample of our GMP products! Request a FREE sample of our GMP products!
Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
IL8-H5217 | Human | Human IL-8 / CXCL8 Protein, premium grade |
|
|
|
CRS-B004 | Human | ClinMax™ Human IL-8 ELISA Kit | |||
IL8-C52H4 | Rhesus macaque | Rhesus macaque IL-8 / CXCL8 Protein, His Tag (MALS verified) |
|
|
|
CEA-C004 | Human | ClinMax™ Human IL-8 ELISA Kit, PRO | |||
IL8-H82H3 | Human | Biotinylated Human IL-8 protein, His,Avitag™ |
|
|
|
IL8-H5258 | Human | Human IL-8 / CXCL8 Protein, Fc Tag |
|
|
|
IL8-H52H3 | Human | Human IL-8 / CXCL8 Protein, His Tag |
|
|
Immobilized Rhesus macaque IL-8 / CXCL8 Protein, His Tag (Cat. No. IL8-C52H4) at 1 μg/mL (100 μL/well) can bind Monoclonal Anti-Human IL-8 Antibody, Human IgG1 with a linear range of 0.1-3 ng/mL (QC tested).
The purity of Rhesus macaque IL-8 Protein, His Tag (Cat. No. IL8-C52H4) is more than 85% and the molecular weight of this protein is around 14-20 kDa verified by SEC-MALS.
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Mouse monoclonal antibody against human interleukin-8 cream | Approved | Dalian Asia Space Pharmaceutical Co Ltd, Dongguan Hongyuan Yishi Biotechnology Pharmaceutical Co Ltd | 恩博克 | Mainland China | Eczema; Psoriasis | Dalian Asia Space Pharmaceutical Co Ltd | 2001-04-10 | Psoriasis; Eczema | Details | |
Mouse monoclonal antibody against human interleukin-8 cream | Approved | Dalian Asia Space Pharmaceutical Co Ltd, Dongguan Hongyuan Yishi Biotechnology Pharmaceutical Co Ltd | 恩博克 | Mainland China | Eczema; Psoriasis | Dalian Asia Space Pharmaceutical Co Ltd | 2001-04-10 | Psoriasis; Eczema | Details |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Ensereptide | PXL-01 | Phase 3 Clinical | Promore Pharma | Post-surgical adhesions; Tissue Adhesions; Cicatrix | Details |
HuMax-IL8 | MDX-018; BMS-986253 | Phase 2 Clinical | Medarex, Genmab A/S, Bristol-Myers Squibb Company | Hematologic Neoplasms; Solid tumours; Carcinoma, Renal Cell; Squamous Cell Carcinoma of Head and Neck; Coronavirus Disease 2019 (COVID-19); Myelodysplastic Syndromes; Prostatic Neoplasms; Carcinoma, Non-Small-Cell Lung; Melanoma; Carcinoma, Hepatocellular | Details |
AMY-109 | AMY-109; AMY109 | Phase 2 Clinical | Chugai Pharmaceutical Co Ltd | Solid tumours; Endometriosis | Details |
AC-701 | AC-701 | Phase 2 Clinical | Twi Pharmaceuticals Inc | Rosacea; Exanthema | Details |
Ensereptide | PXL-01 | Phase 3 Clinical | Promore Pharma | Post-surgical adhesions; Tissue Adhesions; Cicatrix | Details |
HuMax-IL8 | MDX-018; BMS-986253 | Phase 2 Clinical | Medarex, Genmab A/S, Bristol-Myers Squibb Company | Hematologic Neoplasms; Solid tumours; Carcinoma, Renal Cell; Squamous Cell Carcinoma of Head and Neck; Coronavirus Disease 2019 (COVID-19); Myelodysplastic Syndromes; Prostatic Neoplasms; Carcinoma, Non-Small-Cell Lung; Melanoma; Carcinoma, Hepatocellular | Details |
AMY-109 | AMY-109; AMY109 | Phase 2 Clinical | Chugai Pharmaceutical Co Ltd | Solid tumours; Endometriosis | Details |
AC-701 | AC-701 | Phase 2 Clinical | Twi Pharmaceuticals Inc | Rosacea; Exanthema | Details |
This web search service is supported by Google Inc.